LifeStance Health Group, Inc. (LFST) Stock Analysis
Breakout setup
Healthcare · Medical Care Facilities
Sell if holding. At $8.62, A.R:R 0.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%).
LifeStance Health operates one of the nation's largest outpatient mental health platforms with 8,040 licensed clinicians in 33 states, treating 1.0M+ unique patients through ~9.0M visits in 2025. Revenue is earned on a per-visit fee-for-service basis, with 90% from commercial... Read more
Sell if holding. At $8.62, A.R:R 0.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%). Chart setup: Golden cross, above all MAs, RSI 67, MACD bullish. Score 5.5/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news events none recent, earnings proximity 51d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
About LifeStance Health Group, Inc.
About LifeStance Health Group, Inc.
LifeStance Health Group employed 8,040 licensed mental health clinicians across 572 centers in 33 states as of December 31, 2025, making it one of the nation's largest outpatient mental health platforms by clinician count and geographic scale. The platform delivered approximately 9.0 million patient visits to more than 1.0 million unique patients in 2025. Revenue is primarily generated through fee-for-service arrangements with commercial in-network payors, which accounted for 90% of total revenue in 2025, with government payors and self-pay contributing 5% and 4%, respectively.
LifeStance earns revenue on a per-visit basis when patients receive care from employed clinicians, either in-person at one of its 572 centers or through the company's virtual care platform. Commercial in-network payors supply 90% of revenue, with UnitedHealthcare and Elevance Health each individually exceeding 10% — comprising 14% and 15% of total revenue in 2025, respectively. Contracts with payors are typically structured as fee-for-service arrangements with negotiated reimbursement rates. Clinicians are employed as W-2 employees rather than independent contractors, a model the company believes strengthens retention but requires ongoing investment in compensation and benefit packages. The company competes with other outpatient mental health providers, hospitals, digital health platforms and major retailers that have recently begun to offer mental healthcare services in certain markets.
Show full overview
Reimbursement risk from the two largest payors is material and named. Elevance Health and UnitedHealthcare together accounted for 29% of 2025 total revenue (14% and 15% per the 10-K disclosure), and the filing states that changes in their reimbursement rates or loss of in-network status may adversely impact results more than changes implemented by other payors. Separately, 5% of revenue comes from government payors subject to statutory rate-setting; the filing cites uncertainty around the One Big Beautiful Bill Act and its potential impact on Medicare and Medicaid funding, which could reduce or delay government program reimbursement.
See also: Healthcare · Medical Care Facilities
From LifeStance Health Group, Inc.'s most recent 10-K filing, extracted June 11, 2026.
Recent developments
updated 2026-06-17Recent Developments — LifeStance Health Group, Inc.
Latest news
- NEWS LifeStance to Present at Upcoming Investor Conferences - GlobeNewswire — GlobeNewswire neutral
- NEWS A LifeStance Health Insider Sold Nearly 70,000 Shares. Here's What That Means for Investors. - The Motley Fool — The Motley Fool negative
- NEWS Robert Bessler Sells LifeStance Health Shares Valued at $492,000 - HarianBasis.co — HarianBasis.co negative
- NEWS A LifeStance Health Insider Sold Nearly 70,000 Shares. Here's What That Means for Investors. - The Globe and Mail — The Globe and Mail negative
- NEWS Why LifeStance Health Group (LFST) Stock Is Up Today - Yahoo Finance — Yahoo Finance positive
Generated 2026-06-17T09:16:55Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerElevance Health15%10-K Item 1A: 'Two payors individually exceeded 10% of our total revenue for the year ended December 31, 2025: UnitedHealthcare and Elevance Health, Inc., comprising 14% and 15% of our total revenue, respectively'
- HIGHCustomerUnitedHealthcare14%10-K Item 1A: 'Two payors individually exceeded 10% of our total revenue for the year ended December 31, 2025: UnitedHealthcare and Elevance Health, Inc., comprising 14% and 15% of our total revenue, respectively'
Material Events(8-K, last 90d)
- 2026-03-11Item 5.02LOWLisa Miller promoted to Chief Operating Officer and Principal Operating Officer effective March 10, 2026. Previously EVP, Practice Operations since February 2024. Internal appointment; no officer departure.SEC filing →
- 2026-02-25Item 5.02LOWKenneth Burdick, Executive Chairman, announced planned transition to non-executive Chairman effective March 16, 2026. Not due to disagreement with management or Board. Will participate in standard non-employee director compensation.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. At $8.62, A.R:R 0.4:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%). Chart setup: Golden cross, above all MAs, RSI 67, MACD bullish. Prior stop was $8.04. Score 5.5/10, moderate confidence.
Take-profit target: $9.18 (+6.5% upside). Prior stop was $8.04. Stop-loss: $8.04.
Concentration risk — Customer: Elevance Health (15.0%); Concentration risk — Customer: UnitedHealthcare (14.0%); Thin upside margin: 6.5%.
LifeStance Health Group, Inc. trades at a P/E of 143.2 (forward 21.9). TrendMatrix value score: 5.6/10. Verdict: Sell.
17 analysts cover LFST with a consensus score of 4.1/5. Average price target: $11.
What does LifeStance Health Group, Inc. do?LifeStance Health operates one of the nation's largest outpatient mental health platforms with 8,040 licensed...
LifeStance Health operates one of the nation's largest outpatient mental health platforms with 8,040 licensed clinicians in 33 states, treating 1.0M+ unique patients through ~9.0M visits in 2025. Revenue is earned on a per-visit fee-for-service basis, with 90% from commercial in-network payors and 5% from government payors.